292 related articles for article (PubMed ID: 15548692)
1. Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.
Aqeilan RI; Palamarchuk A; Weigel RJ; Herrero JJ; Pekarsky Y; Croce CM
Cancer Res; 2004 Nov; 64(22):8256-61. PubMed ID: 15548692
[TBL] [Abstract][Full Text] [Related]
2. WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins.
Ludes-Meyers JH; Kil H; Bednarek AK; Drake J; Bedford MT; Aldaz CM
Oncogene; 2004 Jun; 23(29):5049-55. PubMed ID: 15064722
[TBL] [Abstract][Full Text] [Related]
3. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.
Guler G; Huebner K; Himmetoglu C; Jimenez RE; Costinean S; Volinia S; Pilarski RT; Hayran M; Shapiro CL
Cancer; 2009 Feb; 115(4):899-908. PubMed ID: 19130459
[TBL] [Abstract][Full Text] [Related]
4. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function.
Aqeilan RI; Donati V; Palamarchuk A; Trapasso F; Kaou M; Pekarsky Y; Sudol M; Croce CM
Cancer Res; 2005 Aug; 65(15):6764-72. PubMed ID: 16061658
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in silico assessment of the effect of WWOX expression on invasiveness pathways associated with AP-2 transcription factors in bladder cancer.
Kałuzińska Ż; Kołat D; Kośla K; Orzechowska M; Bednarek AK; Płuciennik E
BMC Urol; 2021 Mar; 21(1):36. PubMed ID: 33691672
[TBL] [Abstract][Full Text] [Related]
6. Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2α and AP-2γ Transcription Factors in Bladder Cancer.
Kołat D; Kałuzińska Ż; Bednarek AK; Płuciennik E
Cells; 2022 Apr; 11(9):. PubMed ID: 35563688
[TBL] [Abstract][Full Text] [Related]
7. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog.
Aqeilan RI; Pekarsky Y; Herrero JJ; Palamarchuk A; Letofsky J; Druck T; Trapasso F; Han SY; Melino G; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4401-6. PubMed ID: 15070730
[TBL] [Abstract][Full Text] [Related]
8. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.
Abu-Odeh M; Bar-Mag T; Huang H; Kim T; Salah Z; Abdeen SK; Sudol M; Reichmann D; Sidhu S; Kim PM; Aqeilan RI
J Biol Chem; 2014 Mar; 289(13):8865-80. PubMed ID: 24550385
[TBL] [Abstract][Full Text] [Related]
9. Physical association with WWOX suppresses c-Jun transcriptional activity.
Gaudio E; Palamarchuk A; Palumbo T; Trapasso F; Pekarsky Y; Croce CM; Aqeilan RI
Cancer Res; 2006 Dec; 66(24):11585-9. PubMed ID: 17178850
[TBL] [Abstract][Full Text] [Related]
10. Cancerous Protein Network That Inhibits the Tumor Suppressor Function of WW Domain-Containing Oxidoreductase (WWOX) by Aberrantly Expressed Molecules.
Saigo C; Kito Y; Takeuchi T
Front Oncol; 2018; 8():350. PubMed ID: 30214895
[TBL] [Abstract][Full Text] [Related]
11. Fragile Gene
Kołat D; Kałuzińska Ż; Płuciennik E
Front Oncol; 2021; 11():621060. PubMed ID: 33718178
[TBL] [Abstract][Full Text] [Related]
12. WW domain-containing oxidoreductase: a candidate tumor suppressor.
Chang NS; Hsu LJ; Lin YS; Lai FJ; Sheu HM
Trends Mol Med; 2007 Jan; 13(1):12-22. PubMed ID: 17142102
[TBL] [Abstract][Full Text] [Related]
13. p73 participates in WWOX-mediated apoptosis in leukemia cells.
Lin D; Cui Z; Kong L; Cheng F; Xu J; Lan F
Int J Mol Med; 2013 Apr; 31(4):849-54. PubMed ID: 23446842
[TBL] [Abstract][Full Text] [Related]
14. WWOX Loses the Ability to Regulate Oncogenic AP-2γ and Synergizes with Tumor Suppressor AP-2α in High-Grade Bladder Cancer.
Kołat D; Kałuzińska Ż; Bednarek AK; Płuciennik E
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34204827
[TBL] [Abstract][Full Text] [Related]
15. A p53/TIAF1/WWOX triad exerts cancer suppression but may cause brain protein aggregation due to p53/WWOX functional antagonism.
Chou PY; Lin SR; Lee MH; Schultz L; Sze CI; Chang NS
Cell Commun Signal; 2019 Jul; 17(1):76. PubMed ID: 31315632
[TBL] [Abstract][Full Text] [Related]
16. The Tumor-Suppressor WWOX and HDAC3 Inhibit the Transcriptional Activity of the β-Catenin Coactivator BCL9-2 in Breast Cancer Cells.
El-Hage P; Petitalot A; Monsoro-Burq AH; Maczkowiak F; Driouch K; Formstecher E; Camonis J; Sabbah M; Bièche I; Lidereau R; Lallemand F
Mol Cancer Res; 2015 May; 13(5):902-12. PubMed ID: 25678599
[TBL] [Abstract][Full Text] [Related]
17. VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX.
Bonin F; Taouis K; Azorin P; Petitalot A; Tariq Z; Nola S; Bouteille N; Tury S; Vacher S; Bièche I; Rais KA; Pierron G; Fuhrmann L; Vincent-Salomon A; Formstecher E; Camonis J; Lidereau R; Lallemand F; Driouch K
BMC Biol; 2018 Oct; 16(1):109. PubMed ID: 30285739
[TBL] [Abstract][Full Text] [Related]
18. Wwox suppresses breast cancer cell growth through modulation of the hedgehog-GLI1 signaling pathway.
Xiong A; Wei L; Ying M; Wu H; Hua J; Wang Y
Biochem Biophys Res Commun; 2014 Jan; 443(4):1200-5. PubMed ID: 24393846
[TBL] [Abstract][Full Text] [Related]
19. The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding.
Ferguson BW; Gao X; Zelazowski MJ; Lee J; Jeter CR; Abba MC; Aldaz CM
BMC Cancer; 2013 Dec; 13():593. PubMed ID: 24330518
[TBL] [Abstract][Full Text] [Related]
20. WW domain containing oxidoreductase induces apoptosis in gallbladder-derived malignant cell by upregulating expression of P73 and PUMA.
Wei D; Zhang X; Zou H; Wang L; Fu B; Wu X; Luo Z; Li X; Ge J; Li Y; Zhu H; Wang K; Wang T; Yang P; Hou Z; Wang W
Tumour Biol; 2014 Feb; 35(2):1539-50. PubMed ID: 24127039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
